Advanced Search
      Login
 
Main Menu



Eosinophilic Esophagitis
Author: Ronald S. Siegel, M.D.
Last Revised: Mon, 05-Feb-2007
Article Size: 6.8 KB

PDF Version

CLINICAL VIGNETTE

Eosinophilic Esophagitis

Ronald S. Siegel, M.D.

The presence of abnormal numbers of eosinophils in the stomach, small bowel and colon has been well-described and causes a variety of symptoms termed eosinophilic gastroenteritis. However, this has rarely been reported in the esophagus. A slight increase in esophageal eosinophils (5-10 per high power field) in the distal esophagus is characteristic of reflux esophagitis,1 but large numbers of eosinophils (>20 per high power field) infiltrating the esophagus is distinctly unusual. Recently, a patient was seen with a variety of clinical and endoscopic findings typical of an unusual form of esophagitis illustrated by the following case.

Case Report

A 32-year-old male presented to the Emergency Department, complaining of difficulty in swallowing for 24 hours after swallowing a large vitamin pill. He reported a long history of intermittent dysphagia for solids but not liquids, although he never had a prior esophageal obstruction. He denied any history of acid reflux symptoms, or peptic ulcer disease. He had no atopic symptoms, but reported an allergy to peanuts. He was not taking any medications. Family history and review of systems were non-contribu-tory. Physical examination was normal except for the presence of large amounts of saliva in the patient's mouth that he was unable to swallow.

An emergency endoscopy was performed, revealing a large pill obstructing the proximal esophagus. The pill was removed endoscopically. Examination of the esophagus revealed no stricture or obstruction. White nodules, 1 to 2 mm in size, were seen scattered along the mucosa, and multiple thin concen-tric mucosal rings were seen extending distally down the esophagus, which appeared narrowed throughout its course. A repeat endoscopy was performed 2 weeks later and biopsies were obtained, which revealed greater than 20 intraepithelial eosinophils per high power field (Figure 1), and multiple eosinophilic microabcesses, both diagnostic of eosinophilic esophagitis. He was treated with topical steroids, consisting of fluticasone, 220 mcg/puff swal-lowed twice daily. His dysphagia resolved over a 4-week period, and has not recurred.


Figure 1. Esophageal biopsy showing marked increase in intraepithelial eosinophils.

Discussion

Initially reported in the 1970s,2,3 there were only a few reports of eosinophilic esophagitis until relatively recently, suggesting an accelerating incidence,4 although no large populations studies have been reported in adults. This disorder usually affects men between age 20 and 30 years, although it can be seen in women and can occur at any age.5 Patients typically present with dysphagia (93%), food impaction (62%), and heartburn (34%), while allergic symptoms are reported in 52%, and peripheral eosinophilia in 31%.6 Endoscopic findings are quite typical and include multiple mucosal rings, strictures, linear furrowing, narrowed esophagus, and multiple white papules, although a small percent of patients will have a normal-appearing esophagus.7 Eosinophilic esophagitis can be suspected clinically, but diagnosis requires pathologic confirmation by finding large numbers of intraepithelial eosinophils throughout the esophagus. The etiology of eosinophilic esophagitis is unknown but atopy and eosinophilia are common, suggesting that eosinophilic infiltration of the esoph-agus may be a response to environmental allergens, leading to esophageal inflammation by the release of a variety of interleukins and cytotoxic proteins.8,9 Current approaches to treatment of eosinophilic esophagitis include allergy avoidance and the use of topical steroids in the form of swallowed fluticasone proprionate, an inhaled corticosteroid used in the management of asthma.10 The long-term prognosis for eosinophilic esophagitis is unclear, but in a study of patients followed for an average of 7 years, the majority of patients had persistent dysphagia although the degree of tissue eosinophilia decreased over time, and no cases of dysplasia or neoplasia were observed.11

REFERENCES

  1. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: A new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83:818-23.

  2. Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74:1298-1301.

  3. Shiflett DW, Gilliam JH, Wu WC, Austin WE, Ott DJ. Multiple esophageal webs. Gastroenterology. 1979;77;556-9.

  4. Straumann A, Simon HU. Eosinophilic esophagitis: Escalating epidemiology? J Allergy Clin Immunol. 2005;115:418-9.

  5. Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516-22.

  6. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: what is the clinical significance? Endoscopy. 2006;38:515-20.

  7. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2006;18:211-7.

  8. Desreumaux P, Bloget F, Seguy D, et al. Interleukin-3, granulocyte-macrophage colony stimulating factor, and interleukin-5 in eosinophilic gastroenteritis. Gastroenterology. 1996;110:768-74.

  9. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 1992;103;137-45.

  10. Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc. 2003;78:830-5.

  11. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU. Natural history of primary eosinophilic esophagitis : a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660-9.



Eosinophilic Esophagitis
© copyright 2009 Stephen Ng & UCLA Department of Medicine


© 2004-2009, Department of Medicine, UCLA
All rights reserved. We make no representations whatsoever about any other Web site that may be accessed through this site. When you access a non-DOM Web site, please understand that it is independent from our organization, and that we have no control over the content of that Web site
for patient related questions email:access@mednet.ucla.edu
for medical school admission info email:somadmiss@mednet.ucla.edu
for questions about this website email:DOMhelp@mednet.ucla.edu